Science & ResearchJul 16, 2026
Continuous or Fixed-Duration Maintenance Therapy in Multiple Myeloma.
Current treatment of newly diagnosed multiple myeloma involves lenalidomide maintenance therapy given until disease progression.
Current treatment of newly diagnosed multiple myeloma involves lenalidomide maintenance therapy given until disease progression. The appropriate duration of maintenance therapy with lenalidomide has been unclear. In this phase 3 trial, we enrolled patients with standard-risk…
Sign in to learn & save →
The frontier is open to all. Sign in to learn this from first principles and save it to your knowledge base.